Advertisement

Topics

Alembic Limited Company Profile

11:30 EST 17th December 2018 | BioPortfolio

At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation technology, strain improvement, industrial enzymes, non-infringing process developments for API & intermediates, development of innovative formulations, NDDS. The Department of Scientific and Industrial Research (DSIR) of the Government of India recognize Alembic's Research and Development Unit since 1975. Research and Development efforts at Alembic are focused on 3 broad categories Chemistry and Synthesis Formulations Development Contract / Collaborated Research

Location

Alembic Road
Vadodara
Gujarat
390003
India

Contact

Phone: +91-265-3007-652
Fax: +91-265-2281-508
Email: bp.saradhi@alembic.co.in


News Articles [41 Associated News Articles listed on BioPortfolio]

Alembic Pharmaceuticals net up by 36% in Q1

Alembic Pharmaceuticals, a Vadodara based Rs.3,100 crore plus pharma major, has posted net profit growth of 35.7 per cent during the first quarter ended June 2018 to Rs.90.47 crore from Rs.66.67 crore...

FDA approves Alembic's major depressive disorder tablets

The FDA has approved Indian drugmaker Alembic Pharmaceuticals' abbreviated new drug application for major depressive disorder -More- 

Alembic gains FDA tentative approval for generic Latisse

Swift And Nimble – Alembic Laps Up US Valsartan Windfall In Q2

Alembic moved fast and seized supply opportunities for valsartan, the hypertension drug that has seen shortages in the US, though...   

Alembic gets tentative FDA nod for generic Brilinta tablets

FDA approves Alembic’s generic Wellbutrin

Plenty Of Potential For Roche's Entrectinib Despite Lack Of ESMO Enthusiasm

Roche's up and down ESMO is best summed up by the response to data presented on its personalised cancer med...   

Positive Phase III For Darolutamide In Prostate Cancer Could Improve Options For Orion

Top-line results from the Phase III ARAMIS study indicate the next-generation oral androgen receptor antagonist, darolutamide, has met its primary...   

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [86 Associated Companies listed on BioPortfolio]

Alembic Limited

At Alembic, we recognize that Research and Development is vital for our survival and growth as a leading pharmaceutical firm in India. Research and Development at Alembic is focussed on fermentation t...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

VASUDHA PHARMA CHEM LIMITED

VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...

More Information about "Alembic Limited" on BioPortfolio

We have published hundreds of Alembic Limited news stories on BioPortfolio along with dozens of Alembic Limited Clinical Trials and PubMed Articles about Alembic Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alembic Limited Companies in our database. You can also find out about relevant Alembic Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record